• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D-二聚体是慢性肝衰竭和肝性脑病患者1年死亡率的预后标志物。

D-dimer is a prognostic marker for 1-year mortality in patients with chronic liver failure and hepatic encephalopathy.

作者信息

He Yi-Shan, Yang Su-Hua, Huang Ze-Yu, Lin Lin, Tong Xue-Cheng, Dai Hong, Xue Yuan

机构信息

College of Changzhou Clinical, Nanjing Medical University, Changzhou, China.

Department of Infectious Diseases, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, China.

出版信息

Hepatol Forum. 2024 Sep 11;5(4):193-197. doi: 10.14744/hf.2023.2023.0065. eCollection 2024.

DOI:10.14744/hf.2023.2023.0065
PMID:39355833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11440220/
Abstract

BACKGROUND AND AIM

Hepatic encephalopathy (HE) is a neuropsychiatric complication of liver failure with poor outcomes. The present study aimed to evaluate the predictive values of D-dimer in patients with HE.

MATERIALS AND METHODS

Patients with chronic liver failure (CLF) and HE were enrolled. Univariate and multivariate logistic analysis was performed to investigate the risk factors for 1-year mortality of HE.

RESULTS

During the first year after diagnosis, 39.2% (65/166) of the patients died. D-dimer was significantly higher in non-survivors (Z=2.617, p<0.01). Both D-dimer and international normalized ratio (INR) positively correlated with Child-Pugh and MELD scores, and negatively correlated with sodium (all p<0.01). Moreover, there was a negative relationship between D-dimer and HE grades (r=-0.168, p=0.031), while the relationship between INR and HE grades was not significant (r=0.083, p=0.289). Multivariate analysis showed that age (odds ratio (OR):1.035, 95% CI:1.004-1.067, p=0.03), D-dimer (OR=1.138, 95% CI:1.030-1.258, p=0.01), ALT (OR=1.012, 95% CI:1.001-1.022, p=0.03), and sodium (OR=0.920, 95% CI:0.858-0.986, p=0.02) were independent risk factors for 1-year mortality. Then, a new model Model(Age_DD_ALT_Na) incorporating age, D-dimer, ALT, and sodium was developed. AUROC of Model(Age_DD_ALT_Na) was 0.732, which was significantly higher than MELD and Child-Pugh scores (AUROC: 0.602 and 0.599, p=0.013 and 0.022).

CONCLUSION

D-dimer is a prognostic marker for 1-year mortality in patients with CLF and HE.

摘要

背景与目的

肝性脑病(HE)是肝功能衰竭的一种神经精神并发症,预后较差。本研究旨在评估D - 二聚体在HE患者中的预测价值。

材料与方法

纳入慢性肝功能衰竭(CLF)合并HE的患者。进行单因素和多因素逻辑回归分析,以研究HE患者1年死亡率的危险因素。

结果

在诊断后的第一年,39.2%(65/166)的患者死亡。非存活者的D - 二聚体显著更高(Z = 2.617,p < 0.01)。D - 二聚体和国际标准化比值(INR)均与Child - Pugh评分及终末期肝病模型(MELD)评分呈正相关,与血钠呈负相关(均p < 0.01)。此外,D - 二聚体与HE分级呈负相关(r = -0.168,p = 0.031),而INR与HE分级的关系不显著(r = 0.083,p = 0.289)。多因素分析显示,年龄(比值比(OR):1.035,95%置信区间(CI):1.004 - 1.067,p = 0.03)、D - 二聚体(OR = 1.138,95% CI:1.030 - 1.258,p = 0.01)、谷丙转氨酶(ALT)(OR = 1.012,95% CI:1.001 - 1.022,p = 0.03)和血钠(OR = 0.920,95% CI:0.858 - 0.986,p = 0.02)是1年死亡率的独立危险因素。然后,构建了一个包含年龄、D - 二聚体、ALT和血钠的新模型Model(Age_DD_ALT_Na)。Model(Age_DD_ALT_Na)的受试者工作特征曲线下面积(AUROC)为0.732,显著高于MELD评分和Child - Pugh评分(AUROC分别为0.602和0.599,p = 0.013和0.022)。

结论

D - 二聚体是CLF合并HE患者1年死亡率的预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/11440220/471416277049/hf-5-193-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/11440220/cb62c330d074/hf-5-193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/11440220/8acb8de9508d/hf-5-193-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/11440220/471416277049/hf-5-193-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/11440220/cb62c330d074/hf-5-193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/11440220/8acb8de9508d/hf-5-193-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/11440220/471416277049/hf-5-193-g003.jpg

相似文献

1
D-dimer is a prognostic marker for 1-year mortality in patients with chronic liver failure and hepatic encephalopathy.D-二聚体是慢性肝衰竭和肝性脑病患者1年死亡率的预后标志物。
Hepatol Forum. 2024 Sep 11;5(4):193-197. doi: 10.14744/hf.2023.2023.0065. eCollection 2024.
2
Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver.肝硬化患者轻微肝性脑病的患病率及相关因素
J Clin Exp Hepatol. 2018 Jun;8(2):156-161. doi: 10.1016/j.jceh.2017.06.005. Epub 2017 Jun 20.
3
The Free Triiodothyronine, Gamma-Glutamyl Transpeptidase and Spontaneous Bacterial Peritonitis Index: A Novel Model for Predicting 1-Year Mortality in Patients with HBV-Related Hepatic Encephalopathy.游离三碘甲状腺原氨酸、γ-谷氨酰转肽酶与自发性细菌性腹膜炎指数:预测乙型肝炎病毒相关肝性脑病患者1年死亡率的新模型
Hepat Med. 2024 Jan 22;16:1-9. doi: 10.2147/HMER.S450638. eCollection 2024.
4
Comparison of four prognostic models and a new Logistic regression model to predict short-term prognosis of acute-on-chronic hepatitis B liver failure.比较四种预后模型和一种新的 Logistic 回归模型预测慢性乙型肝炎肝衰竭急性发作的短期预后。
Chin Med J (Engl). 2012 Jul;125(13):2272-8.
5
Performance of Disease-Specific Scoring Models in Intensive Care Patients with Severe Liver Diseases.特定疾病评分模型在重症肝病重症监护患者中的表现
J Clin Diagn Res. 2017 Jun;11(6):OC12-OC16. doi: 10.7860/JCDR/2017/24543.9980. Epub 2017 Jun 1.
6
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).肝硬化患者因肝性脑病住院的特征、风险因素和死亡率,伴有和不伴有慢加急性肝衰竭(ACLF)。
J Hepatol. 2014 Feb;60(2):275-81. doi: 10.1016/j.jhep.2013.10.004. Epub 2013 Oct 12.
7
Prognostic performance of clinical indices and model scorings for acute-on-chronic liver failure: A study of 164 patients.慢性肝衰竭急性发作的临床指标及模型评分的预后性能:一项对164例患者的研究。
Exp Ther Med. 2016 Apr;11(4):1348-1354. doi: 10.3892/etm.2016.3037. Epub 2016 Jan 29.
8
[Analysis of the clinical predictive value of lactate on the prognosis of patients with acute-on-chronic liver failure combined with infection].[乳酸对慢性肝衰竭急性发作合并感染患者预后的临床预测价值分析]
Zhonghua Gan Zang Bing Za Zhi. 2023 Mar 20;31(3):300-306. doi: 10.3760/cma.j.cn501113-20230224-00077.
9
Increased Level of Interleukin 6 Associates With Increased 90-Day and 1-Year Mortality in Patients With End-Stage Liver Disease.白细胞介素 6 水平升高与终末期肝病患者 90 天和 1 年死亡率升高相关。
Clin Gastroenterol Hepatol. 2018 May;16(5):730-737. doi: 10.1016/j.cgh.2017.09.017. Epub 2017 Sep 14.
10
Prediction and Risk Factors for Prognosis of Cirrhotic Patients with Hepatic Encephalopathy.肝硬化合并肝性脑病患者预后的预测及危险因素
Gastroenterol Res Pract. 2021 Oct 18;2021:5623601. doi: 10.1155/2021/5623601. eCollection 2021.

本文引用的文献

1
Elevated plasma D-dimer levels are associated with the poor prognosis of critically ill children.血浆D-二聚体水平升高与危重症儿童的不良预后相关。
Front Pediatr. 2022 Sep 23;10:1001893. doi: 10.3389/fped.2022.1001893. eCollection 2022.
2
D-dimer, a predictor of bad outcome in gastric cancer patients undergoing radical resection.D-二聚体,可预测接受根治性切除术的胃癌患者的不良预后。
Sci Rep. 2022 Sep 30;12(1):16432. doi: 10.1038/s41598-022-16582-9.
3
Hepatic Encephalopathy and Treatment Modalities: A Review Article.肝性脑病及其治疗方式:一篇综述文章
Cureus. 2022 Aug 14;14(8):e28016. doi: 10.7759/cureus.28016. eCollection 2022 Aug.
4
Hepatic Encephalopathy: Current and Emerging Treatment Modalities.肝性脑病:现有和新兴的治疗方式。
Clin Gastroenterol Hepatol. 2022 Aug;20(8S):S9-S19. doi: 10.1016/j.cgh.2022.04.034.
5
Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis.血浆氨水平可预测肝硬化临床稳定门诊患者的肝相关并发症和死亡率。
J Hepatol. 2022 Dec;77(6):1554-1563. doi: 10.1016/j.jhep.2022.07.014. Epub 2022 Jul 22.
6
Analysis of the Dose-Response Relationship Between the International Normalized Ratio and Hepatic Encephalopathy in Patients With Liver Cirrhosis Using Restricted Cubic Spline Functions.应用限制三次样条函数分析国际标准化比值与肝硬化患者肝性脑病的剂量-反应关系。
Front Public Health. 2022 Jun 28;10:919549. doi: 10.3389/fpubh.2022.919549. eCollection 2022.
7
Predictive value of elevated serum D-dimer for short-term prognosis in patients with HBV-related acute-on-chronic liver failure.血清D-二聚体升高对HBV相关慢加急性肝衰竭患者短期预后的预测价值
Exp Ther Med. 2022 May 30;24(1):472. doi: 10.3892/etm.2022.11399. eCollection 2022 Jul.
8
Hepatic encephalopathy.肝性脑病。
Nat Rev Dis Primers. 2022 Jun 23;8(1):43. doi: 10.1038/s41572-022-00366-6.
9
Management of Hepatic Encephalopathy Associated with Advanced Liver Disease.肝性脑病与晚期肝病的管理。
Clin Drug Investig. 2022 Jun;42(Suppl 1):5-13. doi: 10.1007/s40261-022-01146-6. Epub 2022 May 10.
10
Acute-on-Chronic Liver Failure.慢加急性肝衰竭
Am J Gastroenterol. 2022 Jun 1;117(6):831-834. doi: 10.14309/ajg.0000000000001748. Epub 2022 Mar 25.